Dr. Edward P. Ambinder M.D.
Hematologist-Oncologist | Hematology & Oncology
1150 5th Ave New York NY, 10128About
Dr. Edward Ambinder is a hematologist oncologist practicing in New York, NY. Dr. Ambinder specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Jawaharlal Institute of Post Graduate Medicine Research, Pondicherry University 1968
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Number of helper T cells and phytohemagglutinin stimulation correlate in cancer patients.
- Hemochromatosis and hepatitis C.
- Advancing high-quality cancer care: cancer biomedical informatics grid supports personalized medicine and the electronic health record.
- A history of the shift toward full computerization of medicine.
- Electronic health records.
- ASCO's Role in Facilitating the Adoption of Electronic Records in Oncology.
- The information age, cyberspace, and cancer.
- Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma.
- Development, implementation, and initial evaluation of a foundational open interoperability standard for oncology treatment planning and summarization.
- Combination chemotherapy with high-dose methotrexate, bleomycin, and cisplatin in management of head and neck squamous cell carcinoma.
- Data Sharing to Support the Cancer Journey in the Digital Era.
- R.A.P.I.D. (Root Aggregated Prioritized Information Display): A single screen display for efficient digital triaging of medical reports.
- Therapeutic leukopheresis of acute myelo-monocytic leukemia in pregnancy.
- Therapeutic leukopheresis of acute myelo-monocytic leukemia in pregnancy.
- High dose methotrexate followed by citrovorum factor reversal in patients with advanced cancer.
Awards
- 2008-2009 New York Super Doctors
Treatments
- Anemia
- Breast Cancer
- Lung Cancer
- Colon Cancer
- Lymphoma
- Ovarian Cancer
- Leukemia
- Extra Corporeal Shockwave Therapy
Professional Memberships
- Member AMERICAN COLLEGE OF PHYSICIANS
- Member AMERICAN SOCIETY OF CLINICAL ONOCOLOGY
Dr. Edward P. Ambinder M.D.'s Practice location
New York, NY 10128Get Direction
Dr. Edward P. Ambinder M.D.'s reviews
Write ReviewPatient Experience with Dr. Ambinder
Recommended Articles
- Touchdown For Lymphoma: Two Teams Put Rivalry Aside For a Cause
Everyone knows that some rivalries can get pretty heated - especially when sports are involved. However, two football teams recognize that there is something more important - supporting a girl with Hodgkin's lymphoma. Although she was a cheerleader for the football team, they are now turning the...
- Overcoming Lymphoma: A South Philly Student's Story
In April of 2018, 18-year-old Alexis Carine was diagnosed with Hodgkin’s lymphoma (HL), a blood cancer that begins in the lymphatic system. Her diagnosis was stage II HL, a cancer found in two or more lymph node areas, and both are either above or below the diaphragm (the muscle located just...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
- Multiple Myeloma: What is Autotransplantation?
During a stem cell transplantation or autotransplantation, the patient receives high chemotherapy dosage which is sometimes done to the entire body to get rid of the cells that are in the bone marrow (including the myeloma cells). Afterwards, the patient receives new stem cells to form...
- Genetic Advancements in Lymphoma Treatment
Cancers are a huge focus for research. Millions of dollars every year are funneled into funding research that could improve treatment methods or find cures for cancer, including blood cancers. Diffuse large B cell lymphoma (DLBCL) is the most common form of non-Hodgkin’s lymphoma (NHL) accounting...
- AstraZeneca Gains United States Approval for Lymphoma Drug
Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...
Nearby Providers
- Dr. Rachel Vivian Kramer M.D.1751 YORK AVE NEW YORK NY 10128
- Dr. Ali Mohammad Ameri MD215 E 95th St New York NY 10128
- Dr. Ian Yudelman Other215 E 95th St New York NY 10128
- Dr. Richard Jay Meyer MD1111 Park Ave New York NY 10128
- Dr. Michael Diaz M.D.1112 Park Ave New York NY 10128
- Dr. Howard Joel Greenberg M.D.1125 PARK AVE NEW YORK NY 10128